Explore

Endoscope Cleaning Product Market Grows with U.S. Companies Leading

Endoscope Cleaning Product Market Grows with U.S. Companies Leading

Endoscope Cleaning Product Market Grows with U.S. Companies Leading

Senators Introduce Bill to Stabilize Radiologist Pay in Medicare Program

Senators Introduce Bill to Stabilize Radiologist Pay in Medicare Program

A bipartisan group of U.S. Senators has introduced the Provider Reimbursement Stability Act, aimed at stabilizing pay for radiologists and other physicians under the Medicare program. The bill, announced on July 30, seeks to address the issue of declining Medicare pay for physicians, which has reportedly fallen by approximately 33% since 2001 when adjusted for inflation. The legislation proposes to reduce significant year-to-year payment fluctuations caused by budget neutrality requirements and to more accurately reflect changes in practice expenses. The bill is co-sponsored by Senators John Boozman, Peter Welch, Roger Marshall, Angus King, Thom Tillis, and Jeanne Shaheen. A companion bill has also been introduced in the House by Rep. Greg Murphy and other lawmakers. The American College of Radiology and a coalition of medical groups have expressed support for the bill, which aims to increase the budget neutrality threshold and index it to the Medicare Economic Index to account for rising practice costs.

Sanders and Cassidy Seek DOJ Update on Contempt Status of Former Steward Health CEO

Sanders and Cassidy Seek DOJ Update on Contempt Status of Former Steward Health CEO

Senators Bernie Sanders and Bill Cassidy have requested an update from the Department of Justice on the contempt status of Ralph de la Torre, former CEO of Steward Health Care. The request follows de la Torre's failure to comply with a subpoena from the Senate Committee on Health, Education, Labor, and Pensions, which is investigating Steward Health Care's financial management. The company filed for bankruptcy in 2024, marking the largest for-profit hospital bankruptcy in U.S. history. The Senators are seeking accountability for de la Torre's alleged financial mismanagement and its impact on healthcare access.

MARTA Board Conducts Final Interviews for Permanent GM/CEO, Decision Expected Soon

MARTA Board Conducts Final Interviews for Permanent GM/CEO, Decision Expected Soon

The Metropolitan Atlanta Rapid Transit Authority (MARTA) Board of Directors has conducted final interviews for the position of General Manager and Chief Executive Officer. This process, which took place on August 10, 2026, is the culmination of a national search to find a permanent successor to lead one of the largest public transit systems in the United States. Jonathan Hunt has been serving as the Interim GM/CEO since August 2025. The search was managed by the Diversified Search Group (DSG), which conducted a comprehensive outreach campaign across the transportation sector, identifying over 250 candidates. The search committee, led by Jennifer N. Ide, Chair of the MARTA Board of Directors, has narrowed the field to three finalists: Cleveland Ferguson III, Jonathan J. Hunt, and Leroy Jones. The board is expected to make a final decision and announce the new GM/CEO at its meeting on August 13, 2026.

Senator Moran's Legislation for Down Syndrome Research Passes Senate, Awaits House Approval

Senator Moran's Legislation for Down Syndrome Research Passes Senate, Awaits House Approval

U.S. Senator Jerry Moran (R-Kan.), co-chair of the Congressional Task Force on Down Syndrome, has successfully led the passage of the DeOndra Dixon INCLUDE Project Act through the Senate. This bipartisan legislation, introduced with Senators John Hickenlooper (D-Colo.), Cory Booker (D-N.J.), and former Senator Markwayne Mullin (R-Okla.), aims to authorize the INCLUDE Project at the National Institutes of Health (NIH). The project focuses on research into co-occurring conditions in individuals with Down syndrome. The act is named in honor of DeOndra Dixon, a Global Down Syndrome Foundation Ambassador, and seeks to continue federal investments in Down syndrome research. The legislation now moves to the U.S. House of Representatives for consideration.

Trump to sign order calling for fewer childhood vaccines and 'more vaccine flexibility'

Trump to sign order calling for fewer childhood vaccines and 'more vaccine flexibility'

U.S. President Donald Trump will sign an executive order on Monday "calling for more vaccine flexibility and research."

Metallium Expands US Operations with New Director Appointments

Metallium Expands US Operations with New Director Appointments

Metallium Expands US Operations with New Director Appointments

JBS taps Wesley Batista Filho as CEO, posts surprise second-quarter loss

JBS taps Wesley Batista Filho as CEO, posts surprise second-quarter loss

By Roberto Samora and Andre Romani SAO PAULO, Aug 10 (Reuters) - Brazil's JBS, the world's largest meatpacker, said on Monday it had named Wesley Batista Filho as chief executive effective January 2027, while posting an unexpected net loss for the second quarter despite record revenue.

Panic Disorder Treatment: Exploring CBT, Medication, and Self-Help Strategies

Panic Disorder Treatment: Exploring CBT, Medication, and Self-Help Strategies

Panic disorder, affecting approximately 2.7% of U.S. adults annually, is a prevalent anxiety condition that often goes undiagnosed or untreated for years. The primary treatment approaches include cognitive behavioral therapy (CBT) and medication, with CBT recognized as the gold-standard first-line psychotherapy. Selective serotonin reuptake inhibitors (SSRIs) are the preferred first-line medication, while benzodiazepines are used for short-term relief but carry a risk of dependency. Non-drug strategies such as breathing exercises, mindfulness, and lifestyle changes are effective adjuncts, particularly for patients who prefer to avoid medication. The guide emphasizes the importance of structured care pathways and patient follow-up to ensure treatment adherence and effectiveness.

MARTA Board Nears Decision on New GM/CEO After National Search

MARTA Board Nears Decision on New GM/CEO After National Search

The Metropolitan Atlanta Rapid Transit Authority (MARTA) Board of Directors is in the final stages of selecting a new General Manager and Chief Executive Officer. After a comprehensive national search, three finalists have been interviewed, with a decision expected at the board meeting on August 13, 2026. The search, conducted by Diversified Search Group, aimed to find a leader with extensive experience in mass transit and a proven track record in managing large-scale projects. The new GM/CEO will be responsible for overseeing MARTA's operations and strategic direction, focusing on safety, customer service, and fiscal responsibility.

HCA Healthcare Expands Clinical Capabilities with New Job Opportunities

HCA Healthcare Expands Clinical Capabilities with New Job Opportunities

HCA Healthcare Expands Clinical Capabilities with New Job Opportunities

Portland Psychiatrist Criticizes Prior Authorization for Delaying Patient Care

Portland Psychiatrist Criticizes Prior Authorization for Delaying Patient Care

Dr. Jeffrey S. Barkin, a psychiatrist in Portland, Maine, has voiced strong criticism against the practice of prior authorization required by insurance companies. In a recent opinion piece, Dr. Barkin described an incident where he prescribed a generic medication for a patient, only to be met with a demand for prior authorization from the insurer. This process, intended to prevent unnecessary treatments, often results in delays and additional administrative burdens for doctors. Dr. Barkin argues that this system turns physicians into clerks and patients into individuals waiting for permission to receive care. He highlights that the administrative costs often exceed the cost of the medication itself, making the process not only inefficient but morally wrong.